- Home
- BOSC vs ENLV Comparison
BOSC vs ENLV Comparison
Compare BOSC & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOSC | ENLV |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 26.6M |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BOSC | ENLV |
|---|---|---|
| Price | $4.27 | $0.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 132.7K | ★ 11.5M |
| Earning Date | 11-25-2025 | 11-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.29 | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $48,333,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.27 | ★ N/A |
| Revenue Growth | ★ 19.49 | N/A |
| 52 Week Low | $3.14 | $0.83 |
| 52 Week High | $6.72 | $2.10 |
Technical Indicators
Market Signals| Indicator | BOSC | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 37.82 | 39.09 |
| Support Level | $4.36 | $0.89 |
| Resistance Level | $4.96 | $1.25 |
| Average True Range (ATR) | 0.26 | 0.11 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 18.82 | 4.23 |
Price Performance
Historical ComparisonAbout BOSC B.O.S. Better Online Solutions
BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.